Biotherapeutics Cell Line Development

PUBLISHED: May 20, 2024

PAGES: 179 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

Description

Global Biotherapeutics Cell Line Development Market to Reach $135.2 Million by 2030

The global market for Biotherapeutics Cell Line Development estimated at US$88.9 Million in the year 2023, is expected to reach US$135.2 Million by 2030, growing at a CAGR of 6.2% over the period 2023-2030. Transfection & Selection Process, one of the segments analyzed in the report, is expected to record 7.9% CAGR and reach US$28.9 Million by the end of the analysis period. Growth in the Single Cell Cloning Process segment is estimated at 5.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $27.1 Million, While China is Forecast to Grow at 5.5% CAGR

The Biotherapeutics Cell Line Development market in the U.S. is estimated at US$27.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$23 Million by the year 2030 trailing a CAGR of 5.5% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6% and 4.7% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Introducing Our Exciting New Report Features for 2024

Full access to influencer engagement stats

Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.

Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities

Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas

Complimentary report updates for one year

Competitor coverage with global market shares of major players

Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies

Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 11 Featured) -

AGC Biologics
Beckman Coulter, Inc.
Becton, Dickinson & Company
Boehringer Ingelheim International GmbH
Catalent, Inc.
EMD Millipore Corporation
Lonza Group Ltd.
MilliporeSigma
ProBioGen AG
Selexis SA
Sony Biotechnology Inc.
Sysmex Corporation
Thermo Fisher Scientific, Inc.

Product Code: MCP16221

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Biotherapeutics Cell Line Development - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 2: World Historic Review for Biotherapeutics Cell Line Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 3: World 16-Year Perspective for Biotherapeutics Cell Line Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Transfection & Selection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 5: World Historic Review for Transfection & Selection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 6: World 16-Year Perspective for Transfection & Selection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Single Cell Cloning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 8: World Historic Review for Single Cell Cloning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 9: World 16-Year Perspective for Single Cell Cloning by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 10: World Biotherapeutics Cell Line Development Market Analysis of Annual Sales in US$ for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES
- Biotherapeutics Cell Line Development Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 11: USA Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 12: USA Historic Review for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 13: USA 16-Year Perspective for Biotherapeutics Cell Line Development by Process - Percentage Breakdown of Value Sales for Transfection & Selection and Single Cell Cloning for the Years 2014, 2024 & 2030
CANADA
- TABLE 14: Canada Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 15: Canada Historic Review for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 16: Canada 16-Year Perspective for Biotherapeutics Cell Line Development by Process - Percentage Breakdown of Value Sales for Transfection & Selection and Single Cell Cloning for the Years 2014, 2024 & 2030
JAPAN
- Biotherapeutics Cell Line Development Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 17: Japan Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 18: Japan Historic Review for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 19: Japan 16-Year Perspective for Biotherapeutics Cell Line Development by Process - Percentage Breakdown of Value Sales for Transfection & Selection and Single Cell Cloning for the Years 2014, 2024 & 2030
CHINA
- Biotherapeutics Cell Line Development Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 20: China Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 21: China Historic Review for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 22: China 16-Year Perspective for Biotherapeutics Cell Line Development by Process - Percentage Breakdown of Value Sales for Transfection & Selection and Single Cell Cloning for the Years 2014, 2024 & 2030
EUROPE
- Biotherapeutics Cell Line Development Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 23: Europe Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 24: Europe Historic Review for Biotherapeutics Cell Line Development by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 25: Europe 16-Year Perspective for Biotherapeutics Cell Line Development by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
- TABLE 26: Europe Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 27: Europe Historic Review for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 28: Europe 16-Year Perspective for Biotherapeutics Cell Line Development by Process - Percentage Breakdown of Value Sales for Transfection & Selection and Single Cell Cloning for the Years 2014, 2024 & 2030
FRANCE
- Biotherapeutics Cell Line Development Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 29: France Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 30: France Historic Review for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 31: France 16-Year Perspective for Biotherapeutics Cell Line Development by Process - Percentage Breakdown of Value Sales for Transfection & Selection and Single Cell Cloning for the Years 2014, 2024 & 2030
GERMANY
- Biotherapeutics Cell Line Development Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 32: Germany Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 33: Germany Historic Review for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 34: Germany 16-Year Perspective for Biotherapeutics Cell Line Development by Process - Percentage Breakdown of Value Sales for Transfection & Selection and Single Cell Cloning for the Years 2014, 2024 & 2030
ITALY
- TABLE 35: Italy Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 36: Italy Historic Review for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 37: Italy 16-Year Perspective for Biotherapeutics Cell Line Development by Process - Percentage Breakdown of Value Sales for Transfection & Selection and Single Cell Cloning for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Biotherapeutics Cell Line Development Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 38: UK Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 39: UK Historic Review for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 40: UK 16-Year Perspective for Biotherapeutics Cell Line Development by Process - Percentage Breakdown of Value Sales for Transfection & Selection and Single Cell Cloning for the Years 2014, 2024 & 2030
REST OF EUROPE
- TABLE 41: Rest of Europe Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 42: Rest of Europe Historic Review for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 43: Rest of Europe 16-Year Perspective for Biotherapeutics Cell Line Development by Process - Percentage Breakdown of Value Sales for Transfection & Selection and Single Cell Cloning for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Biotherapeutics Cell Line Development Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 44: Asia-Pacific Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 45: Asia-Pacific Historic Review for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 46: Asia-Pacific 16-Year Perspective for Biotherapeutics Cell Line Development by Process - Percentage Breakdown of Value Sales for Transfection & Selection and Single Cell Cloning for the Years 2014, 2024 & 2030
REST OF WORLD
- TABLE 47: Rest of World Recent Past, Current & Future Analysis for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 48: Rest of World Historic Review for Biotherapeutics Cell Line Development by Process - Transfection & Selection and Single Cell Cloning Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 49: Rest of World 16-Year Perspective for Biotherapeutics Cell Line Development by Process - Percentage Breakdown of Value Sales for Transfection & Selection and Single Cell Cloning for the Years 2014, 2024 & 2030